Hiding in Plain Sight: Soluble Immunomodulatory Receptors

Lekh N Dahal; Herbert Schwarz; Frank J Ward

doi:10.1016/j.it.2018.08.004

Hiding in Plain Sight: Soluble Immunomodulatory Receptors

Lekh N Dahal (Corresponding Author)
, Herbert Schwarz
, Frank J Ward

Medical Sciences

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

Original language	English
Pages (from-to)	771-774
Number of pages	4
Journal	Trends in Immunology
Volume	39
Issue number	10
Early online date	5 Sept 2018
DOIs	https://doi.org/10.1016/j.it.2018.08.004
Publication status	Published - Oct 2018

Bibliographical note

We thank Professor Mark S. Cragg, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK for critical reading of the manuscript.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.it.2018.08.004Licence: Unspecified

Cite this

@article{63d080fb1cc241ec8af7815ea892d109,

title = "Hiding in Plain Sight: Soluble Immunomodulatory Receptors",

abstract = "Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.",

author = "Dahal, \{Lekh N\} and Herbert Schwarz and Ward, \{Frank J\}",

note = "We thank Professor Mark S. Cragg, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK for critical reading of the manuscript. ",

year = "2018",

month = oct,

doi = "10.1016/j.it.2018.08.004",

language = "English",

volume = "39",

pages = "771--774",

journal = "Trends in Immunology",

issn = "1471-4906",

publisher = "Elsevier Limited",

number = "10",

}

TY - JOUR

T1 - Hiding in Plain Sight

T2 - Soluble Immunomodulatory Receptors

AU - Dahal, Lekh N

AU - Schwarz, Herbert

AU - Ward, Frank J

N1 - We thank Professor Mark S. Cragg, Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK for critical reading of the manuscript.

PY - 2018/10

Y1 - 2018/10

N2 - Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

AB - Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.

U2 - 10.1016/j.it.2018.08.004

DO - 10.1016/j.it.2018.08.004

M3 - Article

C2 - 30195467

SN - 1471-4906

VL - 39

SP - 771

EP - 774

JO - Trends in Immunology

JF - Trends in Immunology

IS - 10

ER -

Hiding in Plain Sight: Soluble Immunomodulatory Receptors

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Cite this